Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,949,228
  • Shares Outstanding, K 104,085
  • Annual Sales, $ 87,990 K
  • Annual Income, $ -84,550 K
  • 60-Month Beta 1.28
  • Price/Sales 101.54
  • Price/Cash Flow N/A
  • Price/Book 20.18
Trade ARWR with:

Options Overview

Details
  • Implied Volatility 67.63%
  • Historical Volatility 35.06%
  • IV Percentile 12%
  • IV Rank 23.48%
  • IV High 89.55% on 03/05/21
  • IV Low 60.90% on 06/17/21
  • Put/Call Vol Ratio 0.05
  • Today's Volume 2,440
  • Volume Avg (30-Day) 1,111
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 39,273
  • Open Int (30-Day) 34,863

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.09
  • Number of Estimates 6
  • High Estimate 0.44
  • Low Estimate -0.31
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +30.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
70.06 +22.24%
on 05/19/21
90.64 -5.52%
on 06/11/21
+13.38 (+18.52%)
since 05/18/21
3-Month
60.52 +41.51%
on 04/12/21
90.64 -5.52%
on 06/11/21
+17.80 (+26.24%)
since 03/18/21
52-Week
32.86 +160.62%
on 09/11/20
92.60 -7.52%
on 02/10/21
+48.92 (+133.22%)
since 06/18/20

Most Recent Stories

More News
Arrowhead Pharmaceuticals Initiates Phase 2b Study of Investigational ARO-APOC3 for Treatment of Severe Hypertriglyceridemia

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has dosed the first patient in AROAPOC3-2001, a Phase 2b clinical study of ARO-APOC3, the company's investigational RNA interference...

ARWR : 85.64 (-0.40%)
Arrowhead Pharmaceuticals to Participate in Upcoming Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

ARWR : 85.64 (-0.40%)
Arrowhead Earns $10 Million Option Exercise Fee

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that Janssen Pharmaceuticals, Inc., (Janssen) part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has delivered written notice...

ARWR : 85.64 (-0.40%)
Arrowhead Pharmaceuticals to Participate in Upcoming Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

ARWR : 85.64 (-0.40%)
Arrowhead Pharmaceuticals Reports Fiscal 2021 Second Quarter Results

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal second quarter ended March 31, 2021. The company is hosting a conference call today, May 4, 2021, at 4:30...

ARWR : 85.64 (-0.40%)
Arrowhead Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 4, 2021 / Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on May 4, 2021 at...

ARWR : 85.64 (-0.40%)
Arrowhead Announces Improvement in Fibrosis after ARO-AAT Treatment in Patients with Alpha-1 Liver Disease

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced positive interim 48-week liver biopsy results from the AROAAT2002 study, an open-label Phase 2 clinical study of ARO-AAT, the company's second...

ARWR : 85.64 (-0.40%)
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 4, 2021, at 4:30 p.m. ET to discuss its financial results for the fiscal second quarter...

ARWR : 85.64 (-0.40%)
Arrowhead Announces ARO-DUX4 as First Muscle Targeted RNAi Candidate Using TRiM(TM) Platform

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced ARO-DUX4 as Arrowhead's first muscle targeted investigational RNAi therapeutic candidate to utilize its proprietary Targeted RNAi Molecule...

ARWR : 85.64 (-0.40%)
Arrowhead Pharmaceuticals Files IND to Begin Phase 2b Study of ARO-APOC3 in Patients with Severe Hypertriglyceridemia

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has submitted an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) for ARO-APOC3, the company's...

ARWR : 85.64 (-0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

3rd Resistance Point 88.93
2nd Resistance Point 87.82
1st Resistance Point 86.73
Last Price 85.64
1st Support Level 84.53
2nd Support Level 83.42
3rd Support Level 82.33

See More

52-Week High 92.60
Last Price 85.64
Fibonacci 61.8% 69.78
Fibonacci 50% 62.73
Fibonacci 38.2% 55.68
52-Week Low 32.86

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar